ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
MDxHealth SA

MDxHealth SA (MDXH)

1.80
-0.11
(-5.76%)
Closed November 13 4:00PM
1.80
0.00
(0.00%)
After Hours: 7:05PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

MDXH News

Official News Only

MDXH Discussion

View Posts
Monksdream Monksdream 2 weeks ago
MDXH under $3
👍️0
Helter Skelter Helter Skelter 1 month ago
You're welcome frans...$MDXH
👍️0
frans frans 2 months ago
thanks Helter for the news
👍️0
Helter Skelter Helter Skelter 2 months ago
See if the broker-dealers-distributors CHURN the shit out of this.

$MDXH -23% at 1.95 in premarket. Looking for 4-6? Gonna take a lot of churning to grab $40,000,000 out of the marketplace, JMO

MDxHealth Announces Pricing of Offering of Ordinary Shares
September 25 2024 - 9:31PM

IRVINE, CA, and HERSTAL, BELGIUM – September 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today announced that it has priced a registered public offering of 20,000,000 ordinary shares of the Company without nominal value (“Ordinary Shares”) in a registered public offering (the “Offering”) at a price to the public of $2.00 per Ordinary Share for total gross proceeds of $40.0 million before deducting commissions and estimated offering expenses. A strategic partner is purchasing 1,500,000 Ordinary Shares in this Offering directly from the Company rather than through the underwriters. In connection with the Offering, mdxhealth has granted the underwriters an option to purchase up to an additional 2,775,000 Ordinary Shares, on the same terms and conditions.

The closing of the Offering is expected to occur on September 27, 2024, subject to the satisfaction of customary closing conditions. The new Ordinary Shares will have the same rights and benefits as, and rank pari passu in all respects, including as to entitlement to dividends and distributions, with, the Company’s existing and outstanding Ordinary Shares and will be entitled to distributions in respect of which the relevant record date or due date falls on or after the date of issue of the new shares.

Mdxhealth intends to use the net proceeds from the Offering for general corporate and working capital purposes, including to fund product development efforts and commercial activities.

TD Cowen and William Blair are acting as joint book-running managers and BTIG, LLC and Lake Street Capital Markets are acting as passive bookrunners for the Offering.

The Ordinary Shares described above are being offered by mdxhealth pursuant to a registration statement previously filed with and subsequently declared effective by the Securities and Exchange Commission (“SEC”). A preliminary prospectus supplement relating to the Offering has been filed with the SEC and is available on the SEC’s website at http://www.sec.gov. This press release does not constitute an offer to sell or a solicitation of an offer to buy securities of the Company nor shall there be any offer, solicitation or sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification or publication of an offering prospectus under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities, if at all, has been or will be made in accordance with the registration requirements of the United States Securities Act of 1933 and the European Prospectus Regulation (Regulation (EU) 2017/1129), as relevant.

Copies of the preliminary prospectus supplement, and accompanying base prospectus relating to this offering, may be obtained from TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, NY 10017, by email at TD.ECM_Prospectus @russwinter; William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, or by telephone at (800) 621-0687, or by email at prospectus@williamblair.com; BTIG, LLC, 350 Bush Street, 9th FL, San Francisco, CA 94104, Attention: Syndicate Department (415-248-2200) or by email at prospectusdelivery@btig.com; and Lake Street Capital Markets, LLC, Attention: Syndicate Department, 920 Second Avenue South, Suite 700 Minneapolis, MN 55402, by telephone at (612) 326-1305, or by email at syndicate@lakestreetcm.com.

For more information:

mdxhealth
info@mdxhealth.com

LifeSci Advisors (IR & PR)
US: +1 949 271 9223
ir@mdxhealth.com
👍️0
Helter Skelter Helter Skelter 2 months ago
Thanks. 😺 See this virgin chart...

Doesn't trade much with this OS, see if I can track down the float.
Ordinary shares, no nominal value per share: 27,288,093 as of December 31, 2023.



$MDXH

👍️0
frans frans 2 months ago
new board belgium company europe
👍️0

Your Recent History

Delayed Upgrade Clock